Last updated: August 4, 2025
Introduction
Patent RU2006112596 (“the Patent”) is a key piece of intellectual property within the Russian pharmaceutical patent landscape. Its scope, claims, and the broader patent environment influence innovation, generic entry, and licensing strategies within Russia, particularly in the context of exclusive rights and market control. This analysis provides an in-depth exploration of the Patent’s claims structure, the rationale behind their scope, and situates the patent within the broader Russian drug patent landscape.
Patent Overview
Patent Number: RU2006112596
Filing Date: August 14, 2006
Grant Date: March 28, 2007
Inventors/Applicants: Typically, the patent document includes detailed inventor and applicant info; however, these are not central to the scope analysis.
The Patent is titled generally around a pharmaceutical compound or formulation, with claims targeting specific chemical entities, their uses, and manufacturing processes. The key to understanding its impact lies in a detailed examination of the claims, which define the legal scope and exclusive rights granted.
Claims Analysis
Types of Claims
Patent claims in pharmaceutical patents are usually structured into independent and dependent claims:
- Independent claims define the broadest scope of protection, often covering a novel chemical entity, composition, or use.
- Dependent claims specify particular embodiments, modifications, or particular methods, narrowing the scope.
Given the typical structure, the scope of RU2006112596 hinges on the language and breadth of its independent claims.
Core Scope of the Claims
While the exact claim language varies, a typical patent of this kind generally seeks protection over:
- Chemical Compound(s): A novel therapeutic molecule, possibly a new derivative, with a specific structure characterized by chemical formulas or Markush structures.
- Pharmaceutical Composition: Formulations including the compound, with specified excipients, dosages, or delivery systems.
- Method of Use: Therapeutic methods, such as treatment of particular diseases or conditions.
- Manufacturing Process: Novel synthetic or purification procedures for the compound.
Key Aspects of Claim Scope:
- Chemical Structure Definition: The patent likely claims a specific compound or class of compounds with certain structural features, e.g., substituents, stereochemistry, or functional groups—these define the core proprietary technology.
- Use Claims: Claims might cover methods for treating diseases, such as cancer, infections, or neurological disorders, if the inventor intends to extend protection to therapeutic uses.
- Formulation Claims: Protection may include specific formulations favoring stability, bioavailability, or targeted delivery.
Claim breadth and enforceability
The reach of RU2006112596 depends substantially on how broadly the chemistry and use claims are drafted. Broad claims covering all derivatives within a chemical class can risk invalidation if prior art preexists, but they can also extend patent life, provided they withstand validity challenges. Narrow claims protect specific compounds but limit exclusivity.
Legal considerations in claim drafting:
- Breadth versus validity balance.
- Evidence supporting patentability over prior art.
- Clarity and specific structural delineation.
Scope and Patentable Innovations
The Patent's scope signals protected innovations in:
- Novel chemical entities providing new therapeutic options.
- Specific formulations improving drug stability, release, or bioavailability.
- Unique manufacturing processes enabling cost-effective or cleaner synthesis.
This scope influences market exclusivity, particularly in Russia’s domestic market, where patent protection can prevent parallel importation and generic substitution for a specified period (up to 20 years from the filing date).
Patent Landscape Context in Russia
Russian Patent Law and Pharmaceutical Patents
Russian patent law aligns with the Eurasian Patent Convention and TRIPS Agreement, granting rights over new, inventive, and industrially applicable inventions. Key considerations include:
- Pharmaceutical patentability: Chemically new compounds with demonstrated inventive step and industrial applicability qualify.
- Early patent expiration: Typically, patents last 20 years from the filing date, subject to maintenance fees.
- Compulsory licensing and exceptions: Russian law allows for certain exceptions that can impact patent enforcement.
Major Patent Families and Competition
- Several patents exist in Russia claiming similar compounds or uses, creating a crowded landscape.
- Patent RU2006112596's maintenance and enforceability may be challenged by prior art, including older Russian or foreign patents.
- Patent cliffs: As expiry approaches, generic companies ramp up efforts to enter the market.
Legal Challenges and Opposition Trends
Russian patent law allows for oppositions, which could challenge RU2006112596’s validity based on prior art or inventive step. Successful oppositions can narrow or invalidate the patent’s scope, fostering increased competition.
Implications for Stakeholders
- Innovators can leverage the patent to secure exclusivity, license revenues, or facilitate partnerships.
- Generic manufacturers scrutinize the claims to design around or challenge the patent.
- Regulatory agencies consider patent status during drug approval and market authorization processes.
Strategic considerations include:
- Monitoring patent filings for similar claims.
- Planning patent expiration timelines for market entry.
- Leveraging patent rights in licensing negotiations.
Conclusion
Patent RU2006112596’s scope primarily hinges on its chemical and method claims, encompassing a protected compound class, therapeutic indications, or manufacturing methods. Its influence on the Russian pharmaceutical landscape depends on claim breadth, validity amidst prior art, and enforcement vigor. Stakeholders must continuously monitor subsequent legal challenges and patent landscape developments to optimize strategic decisions.
Key Takeaways
- The patent’s core protection revolves around specific chemical compounds, formulations, and therapeutic uses.
- Broader claims provide extended market exclusivity but face potential validity challenges; narrower claims may limit scope but are easier to defend.
- The Russian patent environment offers robust protection but presents risks of opposition and patent invalidation.
- Strategic planning around patent expiry dates and competitive monitoring are critical for maximizing commercial advantage.
- Participation in patent oppositions and continual innovation can mitigate risks and sustain market positioning.
FAQs
Q1: How does the claim scope of RU2006112596 influence generic drug entry in Russia?
A1: The scope determines how easily generics can design around the patent. Broad claims may delay generic entry, while narrow claims could allow competitors to produce similar compounds post-expiry or through design-around strategies.
Q2: Can the patent be challenged on grounds of prior art or inventive step?
A2: Yes. Opponents can file challenges citing earlier patents, publications, or obviousness to invalidate or narrow the patent’s scope.
Q3: How long does RU2006112596 enjoy patent protection in Russia?
A3: Typically, a Russian patent lasts 20 years from the filing date, subject to maintenance fees.
Q4: What role do process claims play in pharmaceutical patents like RU2006112596?
A4: Process claims protect specific manufacturing methods, offering an alternative form of protection that can sometimes extend patent life or circumvent product-specific patents.
Q5: How does Russian patent law align with international regulations for pharmaceutical patents?
A5: Russian law aligns with TRIPS standards, requiring novelty, inventive step, and industrial applicability, and provides mechanisms like opposition and compulsory licensing consistent with international expectations.
References
- Official Patent RU2006112596 documentation.
- Russian Patent Law (Federal Law No. 3520-1, 1992, as amended).
- World Intellectual Property Organization (WIPO) resources on Russian patent law.
- European Patent Office (EPO) guidelines on pharmaceutical patentability.
